News Mar 25, 2023
Porton Delivers Strong 2022 Performance with 127% Sales Growth
News Mar 25, 2023
Porton Released 2022 CSR Report

News Mar 09, 2023
Porton Gets Above-Average S&P Global Environmental, Social, and Governance (ESG) Score
News Mar 09, 2023
Porton Released 2022 CSR Report

News Dec 15, 2022
Porton Pharma Solutions Recognized by Roche Group as a Leading CDMO Service Provider

News Aug 23, 2022
Porton Reports Strong Interim Results 2022

News Aug 11, 2022
Porton Pharma Solutions Ltd. to Expand Operations in Europe

News Mar 11, 2022
Porton Announced to Acquire China Gateway Pharmaceutical Development Co., Ltd.

News Mar 02, 2022
Porton Plans to Invest 420 million to Expand CDMO Production Capacity of Small Molecule API